Loading Events

« All Events

  • This event has passed.

Antimicrobial Resistance – Genomes, Big Data and Emerging Technologies Virtual Conference

November 4 2020 @ 1:00 PM - November 6 2020 @ 7:00 PM

This year the conference will highlight the role of genomic evidence – from internal and external environments as well as its role in the detection, tracking and control of antimicrobial resistance, especially in low- and middle-income countries.

Topics will include:

  •         Global burden of disease from drug-resistant infections: monitoring and evaluation
  •         Genomic evidence that informs the debate on the role of external and internal environments in AMR
  •         Genomic surveillance and epidemiology: its role in detection, tracking and control of antimicrobial resistance in LMIC
  •         Vaccines against AMR
  •         Translating bacterial genomics and metagenomics into clinical practice

Abstract deadline is 8th September 2020, registration deadline is 28th October 2020. Please see the Wellcome Genome Campus website for more information.

With any Whole Genome Sequencing (WGS) test ordered, a Record of Discussion (RoD) form will also need to be submitted. This document is to record the patient’s consent for genomic testing and their choice on taking part in research. Guidance on the patient choice conversation can be found here
This RoD form will be available for clinicians to download from this webpage. Once completed with the patient, it can be send to the lab with the corresponding test order form and sample.
Tests available to order will be listed in the National Genomic Test Directory. A test order form will soon be made available for clinicians on this webpage to download and complete. This form will include the address of the laboratory that the appropriate sample and completed form needs to be sent to.
Until the new Genomic Laboratory Service goes live, please continue to follow existing test order processes.
Later this year, the online test ordering tool for Whole Genome Sequencing will be integrated into the National Genomics Informatics System (NGIS) and clinicians will be able to search or filter to find a clinical indication, confirm eligibility criteria and start the test request process for their patient.